Description
BLOOD BANK PRODUCTS
First action · last action
2026-03-26 · 2026-03-26
Transactions
1
First transaction's obligation
$324,605
Base + all options value (sum of deltas)
$324,605
Extent competed
COMPETED UNDER SAP
Other than full & open authority
—
Set-aside
—
Offers received
—
SDVOSB flag on record
No
Parent IDV
36C25626D0050
NAICS
621991 · BLOOD AND ORGAN BANKS
Modification chain · 1 transaction
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2026-03-26+$324,605= $324,605
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2026-03-26 | +$324,605 | $324,605 | BLOOD BANK PRODUCTS |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI SCFJBJWLMXT6)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C25626D0050 | 256-NETWORK CONTRACT OFFICE 16 (36C256) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $0 | FY2026 |
| 36C25626N0432 | 256-NETWORK CONTRACT OFFICE 16 (36C256) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $245,189 | FY2026 |
| 36C25626N0069 | 256-NETWORK CONTRACT OFFICE 16 (36C256) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $135,008 | FY2026 |
| 36C25625N0652 | 256-NETWORK CONTRACT OFFICE 16 (36C256) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $162,292 | FY2025 |
| 36C25625N0007 | 256-NETWORK CONTRACT OFFICE 16 (36C256) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $307,339 | FY2025 |
| 36C25624N0679 | 256-NETWORK CONTRACT OFFICE 16 (36C256) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $105,590 | FY2024 |
Other recipients under 6550 from 256-NETWORK CONTRACT OFFICE 16 (36C256) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36C25626P0524 | ROCHE DIAGNOSTICS CORPORATION | 256-NETWORK CONTRACT OFFICE 16 (36C256) | $134,375 | FY2026 |
| 36C25626N0413 | TOSOH BIOSCIENCE, INC. | 256-NETWORK CONTRACT OFFICE 16 (36C256) | $32,760 | FY2026 |
| 36C25626N0406 | CEPHEID | 256-NETWORK CONTRACT OFFICE 16 (36C256) | $800,000 | FY2026 |
| 36C25626D0035 | CEPHEID | 256-NETWORK CONTRACT OFFICE 16 (36C256) | $0 | FY2026 |
| 36C25626P0326 | CEPHEID | 256-NETWORK CONTRACT OFFICE 16 (36C256) | $379,242 | FY2026 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C25626N0450_3600_36C25626D0050_3600 · retrieved 2026-09-26.